Detalles de la búsqueda
1.
Long-term safety of once-daily indacaterol acetate/glycopyrronium bromide/mometasone furoate high-dose, and indacaterol acetate/mometasone furoate high-dose, in Japanese patients with inadequately controlled asthma: Results from two open-label, 52-week studies.
J Asthma
; 60(2): 403-411, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35348408
2.
Confidence intervals for exposure-adjusted rate differences in randomized trials.
Pharm Stat
; 21(1): 103-121, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34342122
3.
Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians.
Asian Pac J Allergy Immunol
; 40(3): 223-231, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32247304
4.
Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids.
Eur Respir J
; 50(2)2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28838980
5.
Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma.
J Asthma Allergy
; 16: 123-134, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36714049
6.
Performance of the Cough and Sputum Assessment Questionnaire (CASA-Q) in COPD: Evidence from Clinical and Online Patient Interaction Studies.
Int J Chron Obstruct Pulmon Dis
; 17: 3087-3096, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36531977
7.
A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma.
Adv Ther
; 39(6): 2365-2378, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35072888
8.
Ligelizumab treatment for severe asthma: learnings from the clinical development programme.
Clin Transl Immunology
; 10(3): e1255, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33747510
9.
One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies.
BMJ Open Respir Res
; 8(1)2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34452934
10.
Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials.
Respir Med
; 180: 106311, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33711782
11.
Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study.
Lancet Respir Med
; 8(10): 987-999, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32653075
12.
Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study.
Lancet Respir Med
; 8(10): 1000-1012, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32653074
13.
SiGe optoelectronic metal-oxide semiconductor field-effect transistor.
Opt Lett
; 32(14): 2022-4, 2007 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17632630
Resultados
1 -
13
de 13
1
Próxima >
>>